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Abstract
Background
Ovulatory menstrual cycles are essential for women’s fertility and needed to prevent bone
loss. There is a medical/cultural expectation that clinically normal menstrual cycles are inev-
itably ovulatory. Currently within the general population it is unknown the proportion of regu-
lar, normal-length menstrual cycles that are ovulatory. Thus, the objective of this study was
to determine the population point prevalence of ovulation in premenopausal, normally men-
struating women. The null hypothesis was that such cycles are ovulatory.
Methods
This is a single-cycle, cross-sectional, population-based study—a sub-study of the HUNT3
health study in the semi-rural county (Nord Trøndelag) in mid-Norway. Participants included
>3,700 spontaneously (no hormonal contraception) menstruating women, primarily Cauca-
sian, ages 20–49.9 from that county. Participation rate was 51.9%. All reported the date
previous flow started. A single, random serum progesterone level was considered ovulatory
if9.54 nmol/L on cycle days 14 to -3 days before usual cycle length (CL).
Results
Ovulation was assessed in 3,168 women mean age 41.7 (interquartile range, [IQR] 36.8 to
45.5), cycle length 28 days (d) (IQR 28 to 28) and body mass index (BMI) 26.3 kg/m2 (95%
CI 26.1 to 26.4). Parity was 95.6%, 30% smoked, 61.3% exercised regularly and 18% were
obese. 1,545 women with a serum progesterone level on cycle days 14 to -3 were pre-
sumed to be in the luteal phase. Of these, 63.3% of women had an ovulatory cycle (n = 978)
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and 37% (n = 567) were anovulatory. Women with/ without ovulation did not differ in age,
BMI, cycle day, menarche age, cigarette use, physical activity, % obesity or self-reported
health. There were minimal differences in parity (96.7% vs. 94.5%, P = 0.04) and major dif-
ferences in progesterone level (24.5 vs. 3.8 nmol/L, P = 0.001).
Conclusion
Anovulation in a random population occurs in over a third of clinically normal menstrual
cycles.
Introduction
Regular, normal length (21–35 days [1]) menstrual cycles are considered a vital sign represent-
ing women’s wellness [2]. Some consider regular menstruation sufficient evidence for ovula-
tion [3] and thus the production of normal progesterone as well as estradiol levels. Ovulation is
important because both ovulation and sufficient luteal phase lengths (duration of progesterone
production) are necessary for fertility. Younger women are more commonly anovulatory [4],
as are those in the menopause transition [4–6]. Studies in healthy, highly screened premeno-
pausal women suggest that 92–97% of regular cycles are ovulatory [7–9]. However, regular
menstrual cycles with normal estradiol levels may lack ovulation [10], due to hypothalamic
adaptations related to nutritional, energetic, socioeconomic and emotional stressors that
women in the population commonly experience [11].
The gold standard for ovulation documentation is direct visualization of an egg being
extruded from the ovary, but many indirectmethods show validated evidence of ovulation,
including urinary progesterone excretion (pregnanediol, PdG)[12,13], the midcycle luteinizing
hormone (LH) peak [14] and salivary or serum progesterone [15] levels. The quantitative effect
of progesterone to raise core temperature is also utilized to document ovulation and luteal
phase lengths [16,17]. One group, however, considered high post-ovulatory progesterone levels
to be “an endocrine/metabolic disorder unique to young women”[18]. Evidence suggests that
silent anovulation within normal-length cycles during the premenopausal years is associated
with common diseases of older women including osteoporosis [19], cardiovascular disease [20]
as well as breast [21] and endometrial [22] cancers.
Population-based large studies of ovulation prevalence are needed to determine whether
ovulation is invariably present or, alternatively, is a common subclinical problem within regu-
lar cycles. The few available random population epidemiological studies in less than 1000
women in total show percentage ovulation prevalences ranging from 73 [20] to 74.3 [23] to
84.4% [24]. An ongoing whole-county health study in Norway (HUNT) afforded an opportu-
nity to ascertain population ovulation prevalence. Thus, the purpose of this study was to cross-
sectionally document ovulation prevalence in a population of spontaneously menstruating pre-
menopausal women by measuring a single cycle-day documented progesterone level. Our null
hypothesis was that regular, normal-length menstrual cycles are ovulatory.
Methods
Study design and enrolment
HUNT3 is the 2006–8 re-examination of the population [25] in a multipurpose health study in
Nord Trøndelag, a semi-rural county with a population of about 132,000. It assessed adults
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20 years of age (overall participation rate 54.1%) [25]. A mailed invitation included compre-
hensive general health and lifestyle questionnaires and the date for an examination. At the
visit, women provided the date of their last menstrual period (LMP), blood samples and com-
pleted additional questionnaires; standardized measurements of blood pressure, height (in cen-
timeters, cm) without shoes and weight (in kilograms, kg) in light clothing were collected. The
menstrual cycle day of the blood sample was defined by LMP.
Participants
A total of 47,293 women were invited and 27,754 women (58.8%) attended. The study cohort
totaled 3709 spontaneously menstruating women ages 20–49.9 after excluding women50
years and those using hormonal contraception or the Levonorgestrel-impregnated intrauterine
device (LNG-IUD). An approximate 10% sample (n = 949) was also provided a form to return
the start date of their next menstrual period (NMP) in a postage-paid envelope (S1 Protocol).
Women were excluded if currently using hormonal contraception including a progestin-
releasing IUD, if they were menopausal, perimenopausal with irregular or abnormal-length
cycles, had a hysterectomy, were immediately post-partum or had lactational amenorrhea. All
women were additionally asked: “Have you had regular periods during the last 12 months?”
Women were excluded who answered “no” (irregular cycles) or who were regularly cycling but
with a reported usual CL<21 d (n = 15) or>35d (n = 10) [1] or had missing CL data (n = 62).
All women signed informed consent; this study was approved by the Regional Committee
for Medical Research Ethics, the Norwegian Data Inspectorate and the Clinical Research Ethics
Board of the University of British Columbia (because of funding by the Canadian Institutes for
Health Research, #H06-00204).
Outcome measures
In an open-ended question, all women were asked to record their usual cycle length (CL)
within the last 12 months as a two-digit, specific number of days. They were also asked to
record the date their last flow started (LMP). The primary outcome was the cycle-timed serum
progesterone threshold level for evidence of ovulation of9.54 nmol/L [15,26]. Because of
uncertainty within the literature and in the medical community, we choose published experts
from three countries and asked them this open-ended question: “If you had a cycle-day related
single serum progesterone level in a population-based cohort of premenopausal regularly men-
struating women,What progesterone threshold would you suggest using to make a diagnosis of
an ovulatory cycle?”The majority (four of five) of reproductive clinical and scientific experts
spontaneously recommended a progesterone threshold of9.54 nmol/L (3.0 ng/mL); a sin-
gle expert recommended 19.1 nmol/L (6.0 ng/mL). Other potential progesterone ovulation
thresholds are also possible; one excludes the follicular phase (8.0 nmol/L)[27] and others are
as low as3.5 nmol/L. Those cycles with indirect hormonal evidence of ovulation are called
ovulatory and those without this are called anovulatory. Based on the date women’s last flow
began (last menstrual period, LMP), a date that women had been instructed to record/remem-
ber in their invitation letter, cycle days 14 to 3 days before the woman’s usual cycle length (CL)
were presumed to be the luteal phase. The progesterone threshold of9.54 nmol/L was used to
provide evidence of ovulation in sera collected during these cycle days. These were also the pre-
sumed luteal phase based on the cohort’s cycle-day distribution of progesterone levels and on
assessment of the population’s cycle-day likelihood of exceeding the progesterone threshold
[27].
Progesterone was analyzed by a direct competitive chemiluminescence immunoassay (CV
4.6% at 74.7 nmol/L) with a listed luteal phase range of 3.8 to 78.9 nmol/L (DiaSorin,
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Sundbyberg, Sweden). A state-of-the-art Biobank processed and stored blood fractions [25,27].
Serum collection, storage and progesterone and estradiol analyses are reported in S2 Protocol.
Reproductive variables were collected by self- and interviewer-administered questionnaires.
Women reported their age at menarche, parity (borne a child) and numbers of live births. They
additionally reported history of hormonal contraceptive and LNG-IUD use, amenorrhea (3
months without flow), infertility (>12 months without conception), lactation, if they were
menopausal and if they had experienced hysterectomy and/or removal of one/both ovaries.
The general health questionnaire included body mass index (BMI) at age 18; history of
cigarette use as current, past or never; alcohol servings per 2-weeks and the frequency of
physical activity, its duration and intensity. Current self-rated health was reported in four
categories (poor, fair, good and very good /excellent health). For purposes of analysis, pre-
obese (BMI = 25–29.9 kg/m2) and obesity (BMI30 kg/m2) were defined according to WHO
criteria. The history of prior use of hormonal contraception was dichotomized into never
and ever users; exercise frequency was dichotomized into<2 and2 hours per week; current
self-rated health was re-coded into two categories: fair and good. Further categorizations
for the multivariable analyses were age (groups of 5 years above the age of 30), grouped cycle
days (16, 17–20, 21–24,25) and serum estradiol (120.0, 121.0–299.0, 300.0–499.0 and
>500.0 pmol/L) levels.
Statistical Analyses
A progesterone threshold of9.54 nmol/L, the primary outcome, was the dependent vari-
able in bi- and multi-variable analyses; other progesterone thresholds (3.5,8.0 and
19.1 nmol/L) were secondarily also assessed. Sensitivity analysis examined the cohort report-
ing both LMP and NMP dates. The analyses were performed by appropriate data distribution-
related parametric or non-parametric methods. Baseline differences were tested by indepen-
dent sample t-test, Mann-Whitney U test or Chi-square tests. The odds ratio for ovulation was
calculated by logistic regression in univariable and multivariable models among women in the
presumed luteal phase; significant univariate predictors were included in the multivariable
logistic regression models. The final model was also assessed for interaction terms. All statisti-
cal tests were two-sided; analyses were performed with SPSS (IBM, Armonk, NY, USA) version
20.
Results
Participant flow through this population-based examination of ovulation point prevalence is
shown in Fig 1. The age-cohort participation rate was 51.9% among the 12,111 women youn-
ger than 50. After exclusion of hormonal contraception, those dropping out and those with
incomplete data, 4,336 women with a hormonal sample remained. Among the 3,709 spontane-
ously menstruating women potentially eligible for assessment of ovulation, a total of 3,236
women (87.2%) reported regular cycles and a usual CL. Those included and those with irregu-
lar cycles (12.8%) who were excluded are compared in Table 1. Excluded women with irregular
cycles were significantly older, heavier, more likely to have experienced amenorrhea, to be
smokers, to have lower self-reported health and mean cycle levels of progesterone and
estradiol.
Median serum progesterone values from all women with regular cycles (n = 3236) are plotted
by cycle day in Fig 2. The cycle day on which women provided blood samples was randomly dis-
tributed; those sampled in cycle days14 or>14 had similar average ages (41.9 versus 41.5),
BMI values (26.3 versus 26.2) and mean cycle lengths (27.4 versus 27.4).
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The main “ovulation prevalence cohort” of 3,168 women (98% of the regularly cycling
cohort) was formed by excluding those not providing a CL or who reported a usual CL outside
of the normal range of 21–35 days. A sub-cohort included 307 women who reported start dates
for both LMP and NMP; they were clinically identical to the main cohort reporting only LMP.
Women in this sub-cohort had slightly higher BMI values (26.8 versus 26.2 kg/m2), reported
slightly lower menarche ages (12.9 versus 13.1 years) and had somewhat lower self-rated good/
excellent health (76.9% versus 81.8%)(data not shown).
Table 2 documents the characteristics of the women in the presumed luteal phase for whom
a serum progesterone was9.54 nmol/L (n = 978, 63.3%) and those with lower levels of pro-
gesterone who were considered anovulatory (n = 567, 36.7%) in that cycle. Women in the pre-
sumed luteal phase (n = 1545) by cycle day and usual CL had a median progesterone level that
was significantly higher (24.5 versus 3.9 nmol/L, p<0.001) than those in follicular/menstrual
Fig 1. Consort-like flowchart of women in the third Nord Trøndelag Health Study (HUNT3, Norway) population-based cohort for assessment of the
ovulation point prevalence. † Indicates women excluded due to pregnancy, childbirth within the last year, hysterectomy with or without single or bilateral
ovariectomy, probable menopause, or missing data.
doi:10.1371/journal.pone.0134473.g001
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phases (n = 1623). Apart from differences in median progesterone and estradiol values, the
only significant difference was that parity tended to be higher in women with ovulatory cycles
(96.7% versus 94.5%, P<0.04); obesity also tended to be less in those who were ovulatory.
Examination of alternate progesterone thresholds for the diagnosis of ovulation among the
1545 women who were in the presumed luteal phase showed that the percentage classified as
ovulatory declined as the potential serum progesterone threshold levels increased (Fig 3).
Using the serum progesterone threshold of19.1 nmol/L, only 45% were ovulatory; with a
threshold of3.5 nmol/L, 84% were ovulatory. Also, the proportion of women with progester-
one levels above the various thresholds was higher in the sub-cohort reporting both NMP and
LMP (n = 133) versus only LMP (n = 1412) (Fig 3) for all threshold levels except19.1 nmol/
L.
Predictors of ovulation using the progesterone primary outcome threshold of9.5 nmol/L
by univariable and multivariable logistic regressions are shown in Table 3. In univariable anal-
ysis, the odds ratio for being ovulatory was lowest in the youngest portion of the cohort. Those
with progesterone measured on cycle days25 were less likely to be ovulatory, as were nullipa-
rous women and those with both higher and lower serum estradiol values. In the multivariable
model adjusted for age, cycle day, estradiol level and parity, and including the cycle day x estra-
diol interaction term, significant ovulation predictors related to age, parity and cycle days all
became non-significant. However, the estradiol level lowest and highest categories remained
important predictors of anovulation with an inverse U-shaped pattern. Serum estradiol levels
Table 1. Characteristics of 3,709 spontaneously menstruating*women ages 20–49.9 in the third Nord-Trøndelag Health Study (HUNT3), Norway
reporting regular or irregular menstrual cycles in the last 12 months.
Characteristics Regular cycles N = 3,236 (87.2%) Irregular cycles N = 473 (12.8%)
Mean/Median/% 95% CI /(IQR) Mean/Median/% 95% CI /(IQR) P value
Age (median) 41.6 (36.8 to 45.5) 41.5 (34.9 to 47.1) 0.7
45 years (%) 29.0% 27.4 to 30.6 36.2% 32.0 to 40.6 0.002
Weight (kg) (mean) 72.9 72.4 to 73.4 75.8 74.3 to 77.3 0.001
Height (cm) (mean) 166.6 166.4 to 166.8 166.7 166.1 to 167.2 0.8
BMI kg/m2 (mean) 26.3 26.1 to 26.4 27.3 26.8 to 27.8 0.001
Obesity (BMI>30 kg/m2) % 18.6% 17.3 to 20.0 26.5% 22.7 to 30.6 0.001
BMI at age 18 kg/m2 (mean) 21.3 21.2 to 21.4 21.6 21.3 to 22.0 0.07
Overweight at age 18 (BMI>25) % 8.3% 7.3 to 9.4 11.3% 8.4 to 15.1 0.06
Menarche age (mean) 13.1 13.0 to 13.1 13.0 12.8 to 13.1 0.1
Days since ﬁrst day in last period 14.1 13.8 to 14.4 -
Cycle length, days (mean) 27.4 27.3 to 27.5 -
Parous ( 1 child) % 95.7% 94.9 to 96.3 94.9% 92.6 to 96.6 0.7
Infertility >12 months % 16.8% 15.4 to 18.3 22.4% 17.7 to 28.0 0.03
Amenorrhea >3 months % 4.9% 4.1 to 5.8 27.6% 22.4 to 33.5 0.001
Ever hormonal contraception % 88.8% 87.5 to 90.0 90.0% 85.7 to 93.2 0.7
Good self-reported health % 81.3% 79.9 to 82.6 65.8% 61.4 to 70.0 0.001
Current smokers % 29.7% 28.2 to 31.4 45.5% 41.0 to 50.0 0.001
Alcohol (# units in 2 weeks) 2 (1 to5) 2 (1 to5) 0.998
Physical activity 2 hours/week 61.3% 59.6 to 62.9 53.6% 49.1 to 58.1 0.03
Progesterone (nmol/L) (cycle median) 4.5 (2.7 to17.2) 3.8 (2.7 to7.3) 0.001
Estradiol (pmol/L) (cycle median) 250.0 (160.0 to 367.1) 216.6 (220.0 to 350.0) 0.001
*Spontaneously menstruating means that they were not currently using hormone contraception.
doi:10.1371/journal.pone.0134473.t001
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120.0 pmol/L and500.0 pmol/L were both associated with very low odds for presumed
ovulation. The interaction term between cycle day and its corresponding estradiol level was sig-
nificant (p<0.05).
Logistic regression was also performed with lower and higher potential serum progesterone
thresholds (3.5,8.0 and19.1 nmol/L) as outcomes (data not shown). Briefly, for all pro-
gesterone thresholds, serum estradiol was statistically significantly associated with ovulation
and showed the same inverse U-shape as reported in Table 3. In an adjusted model for evi-
dence of ovulation with a progesterone threshold of8.0 nmol/L as outcome, age also showed
an inverse U-shaped association. The interaction term “cycle day x serum estradiol” was also
statistically significant in all these models.
Discussion
This first investigation of ovulation prevalence in a large random population-based sample
showed that ovulation point prevalence was 63 to 74 percent using an accepted and validated
serum progesterone threshold of9.54 nmol/L in women ages 20–49.9 with spontaneous, reg-
ular and normal-length menstrual cycles. In this single cycle, 26–37 percent of cycles showed
evidence for anovulation based on a lower than threshold progesterone level despite the expec-
tation that regularly menstruating premenopausal women with normal cycle lengths would
always or inevitably be ovulatory [3]. The null hypothesis was rejected.
Those women in the presumed luteal phase who did and did not show evidence of ovulation
were virtually identical; this suggests spontaneous or sporadic rather than chronic anovulation.
Based on these and other data [11,20] we now postulate that anovulation is something that
Fig 2. Median serum progesterone levels in nmol/L across a studiedmenstrual cycle by cycle days in 3236 spontaneously menstruating
premenopausal women aged 20–49.9 with regular cycles in HUNT3 (Norway) study.
doi:10.1371/journal.pone.0134473.g002
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intermittently occurs in all or most women [19]. Prospective population-based data are now
needed to ascertain the within-woman variation in ovulation over time and the incidence of
anovulation in women initially documented to be ovulatory in several consecutive cycles.
The prevalence of silent anovulation in over a third of clinically normal menstrual cycles
within a large population appears to mandate a new understanding of women’s reproductive
physiology. This ovulatory variability perhaps occurs because each menstrual cycle’s hormone
levels are created by a single, uniquely stimulated follicle (rather than by the whole ovary or
gland as is usual in endocrinology). In addition, each follicle is stimulated to egg-release under
tight hypothalamic-pituitary hormonal feedback controls with multiple hypothalamic and lim-
bic inputs. This coordinated ovulation feedback creates a sensitive, adaptive system to allow
temporary reproductive suppression during duress [11]. Limbic system affective/emotional
and nutritional feedbacks into the hypothalamic-pituitary-ovarian axis occur through the neg-
ative influence of increased corticotrophin releasing hormone on gonadotrophin-releasing hor-
mone in response to stressors [11,28,29] often with different threats acting synergistically [28].
Data suggest that ovulation suppression is the most common reproductive adaptation to
various stressors [30]. For example, ovulatory disturbances (anovulation and short luteal
phases) within regular menstrual cycles in normal-weight women are associated with cognitive
dietary restraint [31]; the higher cortisol levels observed in those with higher restraint scores
suggests that this attitude toward food and eating, despite lack of weight abnormalities or
Table 2. Characteristics of 1545 spontaneously* normally menstruating premenopausal women who, by cycle days and usual cycle length (CL)
were in the presumed luteal phase in HUNT3 (Norway) comparing those ovulatory by a serum progesterone threshold of9.54 nmol/L with those
without apparent ovulation.
Women in the presumed luteal phase N = 1545 Progesterone 9.54 nmol/L N = 978
(63.3%)
Progesterone <9.54nmol/L N = 567
(36.7%)
Mean/Median/% 95% CI /(IQR) Mean/Median/% 95% CI /(IQR)
Age (median) 41.8 (37.3 to 45.4) 42.2 (36.6 to 45.8)
Age>45 (%) 29.0% 26.3 to 32.0 31.7% 28.1 to 35.7
Weight (kg) mean 72.6 71.7 to 73.5 73.3 72.2 to 74.4
Height (cm) mean 166.47 166.0 to 166.8 166.3 165.8 to 166.8
BMI (kg/m2)(mean) 26.2 25.9 to 26.5 26.5 26.1 to 26.9
Obesity (BMI>30 kg/m2) (%) 16.9% 14.7 to 19.4 20.7% 17.5 to 24.2
BMI at age 18 (kg/m2) mean 21.3 21.1 to 21.4 21.4 21.2 to 21.7
Overweight at age 18 (BMI>25) % 7.2% 5.6 to 9.3 10.0% 7.5 to 13.2
Menarche age (mean) 13.1 13.0 to 13.2 13.1 12.9 to 13.2
Menstrual cycle day (median) 21 (17 to24) 21 (17 to25)
Cycle length (mean) 27.4 27.2 to 27.5 27.4 27.2 to 27.6
Parous ( 1 child) (%) 96.7% 95.4 to 97.7 94.5% 92.3 to 96.1
Infertility >12 months (%) 15.5% 13.0 to 18.2 15.8% 12.6 to 19.6
Amenorrhea >3 months (%) 4.5% 3.2 to 6.3 5.8% 3.9 to 8.5
Ever hormonal contraception % 90.1% 87.7 to 92.0 90.4% 87.2 to 92.9
Self-report good health (%) 82.8% 80.2 to 85.0 81.7% 78.3 to 84.7
Current smokers % 29.9% 27.1 to 32.9 29.9% 26.3 to 33.8
Alcohol (# units in 2 weeks) 3 (1 to 5) 2 (1 to 5)
Physical activity2 hours/week 60.5% 57.4 to 63.5 60.7% 56.7 to 64.7
Progesterone serum (median)nmol/L 24.5 (17.8 to 32.8) 3.9 (2.4 to 5.7)
Estradiol serum (median) pmol/L 290.0 (220 to 370) 230.0 (130 to 420.0)
*Spontaneously menstruating means that they were not currently using hormonal contraception.
doi:10.1371/journal.pone.0134473.t002
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changes, is intrinsically stressful [32]. Likewise, women with early miscarriages have higher
cortisol levels than do women who carry pregnancies to term [33]; first trimester miscarriages
are also associated with lower serum progesterone levels, higher self-reported stresses and
lower body weights [34].
Progesterone values from different populations differ even when measured using the same
methodology and within conception cycles [35]. Also, within one geographic ethic group,
women who are advantaged (in health care, education and socioeconomic status) appear to
have higher progesterone levels than women who are disadvantaged [36]. Seasons in the
Northern hemisphere have also been associated with ovulatory disturbances; these season-
related ovulatory disturbances increase when concurrent with increased work/energetic
demands [23]. Circumannual changes are related to reproduction through light-dark cycles
and pineal melatonin signaling. Thus there are multiple regulatory influences that may
decrease the prevalence of ovulation.
It is increasingly evident that silent anovulation within clinically normal menstrual cycles is
relevant for women’s health as well as for fertility. Subclinical ovulatory disturbances are asso-
ciated with annual increased spinal bone losses of -0.86% [19] even when estradiol levels are
normal [10]. Increased bone formation through progesterone’s receptor-based osteoblast
Fig 3. Bar graph of the 1545 women from the HUNT3 (Norway) ovulation study with progesterone levels during cycle days in the presumed luteal
phase (cycle days 14 to -3 before usual cycle length) showing the percentage of women that were ovulatory using different threshold serum
progesterone levels and by whether they reported the prescreening date menstrual flow started (LMP, cross-hatched bars, n = 1412) or were in a
sub-cohort reporting both the LMP and post-screeningmenstrual flow dates (NMP, open bars, n = 133). Differences between ovulatory percentages
in the two cohorts were significant for progesterone thresholds of3.5,8.0 and9.54 nmol/L.
doi:10.1371/journal.pone.0134473.g003
Anovulation in Over a Third of Normal Menstrual Cycles
PLOS ONE | DOI:10.1371/journal.pone.0134473 August 20, 2015 9 / 14
stimulating actions [37] is needed to prevent bone loss [19]. Ovulatory disturbances are also
related to women’s risks for later-life heart disease [20,38,39] and likely also to breast [21] as
well as endometrial cancer risks [22].
The anovulation rate in regular menstrual cycles found in this study is similar to results
using different ovulation assessment methods including urinary PdG in a nested within popu-
lation-based two-cycle study in 65 women by Sowers [24] or in 180 women reported by Gor-
gels [20]. Ovulation point prevalence in such a large population-based sample has not
previously been reported.
This study, although in a large cohort, has some limitations including that it is cross-sec-
tional, studied a single cycle, was primarily in white women and, of necessity used an indirect
measure of ovulation. Despite the fact that a progesterone ovulatory threshold of 9.54 nmol/L
has not been validated against direct visualization of an egg being extruded from the ovary, or
serial ultrasounds, it was the spontaneous recommendation of the majority of reproductive
Table 3. Univariable andmultivariable logistic regression of the likelihood of ovulation in spontaneously (without hormonal contraception) and
regularly menstruating women aged 20–49.9 based on a serum progesterone level of9.54 nmol/L in HUNT3 (Norway)#.
Serum Progesterone 9.54 nmol/L
Univariable analysis Multivariable analysis^
N % OR 95% CI OR 95% CI
Age^ <30 50 50.5 0.51 0.31 to 0.84 0.60 0.32 to 1.11
(years) 30–34 115 66.9 1.0 Ref. 1.0 Ref.
35–39 215 66.2 0.97 0.66 to 1.43 0.79 0.51 to 1.24
40–44 314 64.7 0.91 0.63 to 1.32 0.80 0.53 to 1.23
45–49 284 61.2 0.78 0.54 to 1.13 0.66 0.43 to 1.02
Cycle day^ 16 219 66.6 1.0 Ref. 1.0 Ref.
(since ﬁrst 17–20 243 59.7 0.74 0.55 to 1.01 0.75 0.47 to 1.18
day of LMP) 21–24 288 68.6 1.10 0.81 to 1.49 1.31 0.81 to 2.12
25 228 58.6 0.71 0.52 to 0.96 0.85 0.54 to 1.36
Estradiol^ 120.0. 21 14.0 0.07 0.05 to 0.12 0.29 0.11 to 0.81
(pmol/L) 121–299 486 68.6 1.0 Ref. 1.0 Ref.
300–499 398 79.0 1.72 12.31 to 2.24 1.58 0.90 to 2.78
500 73 39.9 0.30 0.22 to 0.42 0.18 0.08 to 0.39
Parous^ Yes 946 63.8 1.0 Ref. 1.0 Ref.
No 32 50.8 0.59 0.35 to 0.97 0.62 0.34 to 1.14
BMI <25 441 64.2 1.0 Ref
(kg/m2) 25–29.9 371 64.6 1.02 0.81 to 1.29
30+ 165 58.5 0.79 0.59 to 1.05
Smoking Never 460 64.9 1.0 Ref.
Prior 218 60.1 0.81 0.63 to 1.06
Current 289 63.2 0.93 0.73 to 1.19
Physically Yes 585 63.1 1.0 Ref.
active >2h/w No 382 63.3 1.01 0.82 to 1.25
Self-reported health Good 788 63.5 1.0 Ref.
Fair 164 61.9 0.93 0.71 to 1.22
#The interaction term (cycle day x estradiol, p<0.05) is included in the multivariable model.
Statistically important relationships are shown in bold.
^Variables signiﬁcant in univariable models that were included in the multivariable model.
doi:10.1371/journal.pone.0134473.t003
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experts and two studies have shown this value to predict progesterone-specific secretory endo-
metrial transformation [15,26]. The mean age of the cohort was regrettably in the early 40s;
younger women in this rural county must leave to obtain post-secondary training and educa-
tion and also were more likely to be excluded because they are using hormonal contraception.
However, included women were all premenopausal (with regular, normal-length cycles); they
are not in the menopausal transition or perimenopause based on recent reproductive aging cri-
teria [40]. The best evidence for an appropriate progesterone threshold (9.54 nmol/L) [15,26]
and cycle days were used. Although latitude may have influenced these data, they were likely
collected randomly across all seasons and thus biases related to light-dark cycles appear
unlikely.
This study also has many strengths. We presented results using an array of potential proges-
terone thresholds, analyzed evidence of ovulation only in those reporting usual cycle lengths of
21–35 days that are considered normal cycle lengths. In addition, we performed a sensitivity
analysis in women who knew cycle day-one dates of both menstrual cycles bracketing the date
of their serum sample. Other strengths are our population-based cohort, that sampling was
random across cycles and that the parent study was related to general health. Given that each
participant has a unique Norwegian identity number, those who did and did not ovulate in
that cycle can be observed prospectively through linkage to national and local disease-specific
and mortality registries for the development of diseases such as osteoporosis that are related to
ovulation disturbances.
Conclusions
This first large population-based assessment of indirect evidence for ovulation’s point preva-
lence using as a primary outcome a serum progesterone threshold of9.54 nmol/L but also
assessing a spectrum of threshold values in a main and a sub-cohort shows that anovulation
likely occurs in more than a third of all clinically normal menstrual cycles. We also noted that
those with/without ovulation in that single cycle differed only minimally. Given increasing evi-
dence that silent ovulatory disturbances within clinically normal cycles are associated with
health risks [19], it is important that these data are replicated in population-based samples of
women of differing racial and ethnic origins and living at different latitudes.
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